These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1693316)

  • 1. Neoadjuvant bleomycin, ifosfamide and cisplatin in cervical cancer.
    Tobias J; Buxton EJ; Blackledge G; Mould JJ; Monaghan J; Spooner D; Chetiyawardana A
    Cancer Chemother Pharmacol; 1990; 26 Suppl():S59-62. PubMed ID: 1693316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience with bleomycin, ifosfamide, and cisplatin in primary and recurrent cervical cancer.
    Buxton EJ
    Semin Oncol; 1992 Apr; 19(2 Suppl 5):9-17; discussion 17-8. PubMed ID: 1384148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised, prospective, phase III clinical trial of primary bleomycin, ifosfamide and cisplatin (BIP) chemotherapy followed by radiotherapy versus radiotherapy alone in inoperable cancer of the cervix.
    Herod J; Burton A; Buxton J; Tobias J; Luesley D; Jordan S; Dunn J; Poole CJ
    Ann Oncol; 2000 Sep; 11(9):1175-81. PubMed ID: 11061615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of ifosfamide in cervical cancer.
    Buxton EJ; Blackledge G; Mould JJ; Monaghan J; Paterson M; Tobias J; Alcock C; Spooner D; Meanwell CA
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):60-7. PubMed ID: 2468183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II studies of ifosfamide alone and in combination in cancer of the cervix.
    Blackledge G; Buxton EJ; Mould JJ; Monaghan J; Paterson M; Tobias J; Alcock C; Spooner D; Meanwell CA
    Cancer Chemother Pharmacol; 1990; 26 Suppl():S12-6. PubMed ID: 1693314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective analysis of concurrent chemoradiation with the combination of bleomycin, ifosfamide and cisplatin (BIP) for uterine cervical cancer.
    Aoki M; Akahira J; Niikura H; Saito S; Abe Y; Aida T; Sato N; Kitamura T; Otsuki K; Katahira A; Utsunomiya H; Okamura C; Takano T; Ito K; Okamura K; Yaegashi N
    Tohoku J Exp Med; 2004 Dec; 204(4):309-15. PubMed ID: 15572856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II studies of bleomycin, ifosfamide and cis-platinum in advanced and recurrent cervical carcinoma.
    Buxton EJ; Meanwell CA; Mould JJ; Latief T; Chetiyawardana AD; Spooner D; Tobias JS; Sokal M; Alcock C; Hilton C
    Acta Oncol; 1988; 27(5):545-9. PubMed ID: 2462439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential for adjuvant therapy in early-stage cervical cancer.
    Buxton EJ; Saunders N; Blackledge GR; Kelly K; Redman CW; Monaghan J; Paterson ME; Luesley DM
    Cancer Chemother Pharmacol; 1990; 26 Suppl():S17-21. PubMed ID: 1693315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary chemotherapy with bleomycin, ifosfamide and cisplatinum (BIP) followed by radiotherapy in the treatment of advanced cervical cancer. A pilot study.
    Nevin J; Bloch B; Van Wijk L; Soeters R; Dehaeck K; Ball H; Denny L
    Eur J Gynaecol Oncol; 1995; 16(1):30-5. PubMed ID: 7538080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination bleomycin, ifosfamide, and cisplatin chemotherapy in cervical cancer.
    Buxton EJ; Meanwell CA; Hilton C; Mould JJ; Spooner D; Chetiyawardana A; Latief T; Paterson M; Redman CW; Luesley DM
    J Natl Cancer Inst; 1989 Mar; 81(5):359-61. PubMed ID: 2464699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The addition of bleomycin and dose-escalated ifosfamide to the combination of cisplatin plus ifosfamide does not improve survival in advanced or recurrent cervical carcinoma.
    Hempling RE; Eltabbakh GH; Piver MS; Recio FO; O'Neill CP
    Am J Clin Oncol; 1997 Jun; 20(3):315-8. PubMed ID: 9167762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of paclitaxel, ifosfamide, and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical carcinoma.
    Scandurra G; Scibilia G; Banna GL; D'Agate G; Lipari H; Gieri S; Scollo P
    J Gynecol Oncol; 2015 Apr; 26(2):118-24. PubMed ID: 25686397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: a Southwest Oncology Group Study.
    Alberts DS; Kronmal R; Baker LH; Stock-Novack DL; Surwit EA; Boutselis JG; Hannigan EV
    J Clin Oncol; 1987 Nov; 5(11):1791-5. PubMed ID: 2445932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
    Zanetta G; Fei F; Mangioni C
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin-ifosfamide as neoadjuvant chemotherapy in stage IIIB cervical uterine squamous-cell carcinoma.
    Lara PC; Garcia-Puche JL; Pedraza V
    Cancer Chemother Pharmacol; 1990; 26 Suppl():S36-8. PubMed ID: 2347047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy for women with locally advanced carcinoma of the uterine cervix--final results of a prospective phase II-study.
    Vrdoljak E; Omrcen T; Novaković ZS; Jelavić TB; Prskalo T; Hrepić D; Hamm W
    Gynecol Oncol; 2006 Nov; 103(2):494-9. PubMed ID: 16814371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of ifosfamide and systemic therapy in the management of carcinoma of the cervix.
    Thigpen T; Vance R; Khansur T; Malamud F
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):56-64. PubMed ID: 8677451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single agent versus combination chemotherapy in recurrent cervical cancer.
    Kumar L; Pokharel YH; Kumar S; Singh R; Rath GK; Kochupillai V
    J Obstet Gynaecol Res; 1998 Dec; 24(6):401-9. PubMed ID: 10063235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy followed by radiotherapy versus radiotherapy alone in locally advanced cervical cancer: a randomized study.
    Kumar L; Kaushal R; Nandy M; Biswal BM; Kumar S; Kriplani A; Singh R; Rath GK; Kochupillai V
    Gynecol Oncol; 1994 Sep; 54(3):307-15. PubMed ID: 7522200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of postoperative simple chemotherapy and concurrent chemoradiotherapy in FIGO stage IB2-IIB cervical cancer].
    Ma K; Yang YH; Yang X; Feng ZY; Liu TY; Wen HW; Liao QP
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Dec; 45(6):910-5. PubMed ID: 24343073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.